Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
To assess motor function and quality of life (QoL) in Parkinson's disease (PD) subjects with
end-of-dose wearing off, comparing immediate and delayed switch to carbidopa/levodopa and
entacapone.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis Pharmaceuticals
Treatments:
Carbidopa Carbidopa, levodopa drug combination Entacapone Levodopa